MFN News
Language
Årsstämman 2023 i Boule Diagnostics AB (publ), (”Boule”), beslutade att en valberedning baserad på ägarförhållandena den 30 september 2023 ska...
06 Nov, 2023
Boule Diagnostics AB: Boule Diagnostics - Inbjudan till presentation av delårsrapport Q3 2023
News
Swedish
IR
Boule Diagnostics AB offentliggör delårsrapporten för perioden januari-september 2023 torsdagen den 9 november 2023 klockan 07:30. Efter offentliggörandet...
06 Nov, 2023
Boule Diagnostics – Inbjudan till presentation av delårsrapport Q3 2023
News
Swedish
IR
Boule Diagnostics AB offentliggör delårsrapporten för perioden januari–september 2023 torsdagen den 9 november 2023 klockan 07:30. Efter offentliggörandet...
14 Sep, 2023
Boule Diagnostics AB: Boule sluter avtal om lokal produktion av instrument i Indien
News
Swedish
IR
Boule Diagnostics har tecknat ett licensavtal med Q-Line Biotech för lokal instrumenttillverkning i Uttar Pradesh, Indien. Indien är en viktig marknad...
Boule Diagnostics har tecknat ett licensavtal med Q-Line Biotech för lokal instrumenttillverkning i Uttar Pradesh, Indien. Indien är en viktig marknad...
24 Jul, 2023
Boule Diagnostics AB: Boule Diagnostics (publ) delårsrapport april-juni 2023
News
Swedish
Regulatory
Report
Interim
IR
Förbättrad bruttomarginal Kvartalet april-juni 2023 *Fondemissionselement från nyemissionen i Q4 2022 har beaktats i beräkningen avseende resultat...
24 Jul, 2023
Boule Diagnostics (publ) delårsrapport april–juni 2023
News
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
IR
Förbättrad bruttomarginal Kvartalet april–juni 2023 *Fondemissionselement från nyemissionen i Q4 2022 har beaktats i beräkningen avseende resultat...
20 Jul, 2023
Boule Diagnostics AB: Boule Diagnostics - Inbjudan till presentation av delårsrapport Q2 2023
News
Swedish
IR
Boule Diagnostics AB offentliggör delårsrapporten för perioden januari-juni 2023 måndagen den 24 juli 2023 klockan 07:30. Efter offentliggörandet...
20 Jul, 2023
Boule Diagnostics – Inbjudan till presentation av delårsrapport Q2 2023
News
Swedish
IR
Boule Diagnostics AB offentliggör delårsrapporten för perioden januari–juni 2023 måndagen den 24 juli 2023 klockan 07:30. Efter offentliggörandet...
29 Jun, 2023
Boule Diagnostics AB: Boule Diagnostics lanserar nytt veterinärinstrument i Europa
News
Swedish
IR
Boule Diagnostics lanserar idag ett nytt veterinärt 5-parts hematologisystem för kostnadseffektiv diagnostik, H50V, på den europeiska marknaden. Systemet...
Boule Diagnostics lanserar idag ett nytt veterinärt 5-parts hematologisystem för kostnadseffektiv diagnostik, H50V, på den europeiska marknaden. Systemet...
Boule Diagnostics AB utser Holger Lembrér till ny CFO med tillträde i januari 2024. Holger Lembrér har en lång karriär från olika ledande finansbefattningar...
28 Oct, 2022
Boule Diagnostics – Nomination Committee for the 2023 Annual General Meeting
News
English
IR
The Annual General Meeting, (”AGM”), 2022 of Boule Diagnostics AB (publ), (”Boule”), decided that a Nomination Committee based on the ownership...
Boule Diagnostics has signed a strategic contract manufacturing agreement with Q-Line Biotech for local hematology reagent manufacturing in India. India...
03 Oct, 2022
Boule Diagnostics resolves on a fully secured preferential rights issue of approximately SEK 150 million
News
English
Regulatory
MAR
IR
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG...
06 Sep, 2022
Clinical Diagnostic Solutions has been issued a Notice of Inspectional Observations by FDA
News
English
IR
Clinical Diagnostic Solutions, Inc. (CDS), a subsidiary to Boule Diagnostics AB, has been issued a Notice of Inspectional Observations (FDA Form 483) by...
Annette Colin has today informed Boule Diagnostics that she is leaving the position as CFO due to family reasons. Annette will continue in her role during...
18 Jul, 2022
Boule Diagnostics (publ) Interim report January–June 2022
News
English
Regulatory
MAR
VPML
Report
Interim
Q2
IR
Continued growth for all products
14 Jul, 2022
Boule Diagnostics – Invitation to presentation of the interim report Q2 2022
News
English
IR
Boule Diagnostics AB will publish the interim report for the period January–June 2022 at 07:30, Monday, July 18th, 2022.
Following the publication...
05 May, 2022
Bulletin from Annual General Meeting in Boule Diagnostics AB on May 5, 2022
News
English
IR
The Annual General Meeting 2022 (the ”AGM”) decided to adopt the balance sheet, income statement, consolidated income statement and consolidated balance...
04 May, 2022
Boule Diagnostics (publ) Interim report January–March 2022
News
English
Regulatory
MAR
Report
Interim
Q1
IR
Double digit growth for all products Quarter January-March 2022 CEO Jesper Söderqvist
Strong growth in sales and improved operating profit
Boule started...
26 Apr, 2022
Boule Diagnostics – Invitation to presentation of the interim report Q1 2022
News
English
IR
Boule Diagnostics AB will publish the interim report for the period January–March 2022 at 10:00, Wednesday, May 4th, 2022. Following the publication...
14 Apr, 2022
Boule Diagnostics publishes the annual report for 2021
News
English
Regulatory
VPML
Report
Annual
IR
Boule Diagnostics AB has published the full Swedish annual report for the fiscal year 2021 at www.boule.com. The annual report is available in Swedish...
The Nomination Committee of Boule Diagnostics AB has decided to propose to the Annual General Meeting 2022 (AGM) that the number of Board members shall...